PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsReviewsEvent Review: European Union Ban on Human Embryonic Stem Cell Patents - A Threat to Science and the Rule of Law

BioNews

Event Review: European Union Ban on Human Embryonic Stem Cell Patents - A Threat to Science and the Rule of Law

Published 15 January 2013 posted in Reviews and appears in BioNews 642

Author

Amy Strange

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.

The recent ruling of the European Court of Justice (ECJ) excluding inventions relating to human embryonic stem cells (ES cells) from patentability has sparked a heated debate in the bioscience, ethics and law communities...


 

European Union Ban on Human Embryonic Stem Cell Patents: A Threat to Science and the Rule of Law

Organised by the University of Oxford

Oxford Martin School, University of Oxford, Old Indian Institute, 34 Broad Street, Oxford OX1 3BD, UK

Friday 20 January 2012

'European Union Ban on Human Embryonic Stem Cell Patents: A Threat to Science and the Rule of Law', organised by the University of Oxford, Friday 20 January 2012

 


The recent ruling of the European Court of Justice (ECJ) excluding inventions relating to human embryonic stem cells (ES cells) from patentability has sparked a heated debate in the bioscience, ethics and law communities (1).

It was the topic up for discussion at a lunchtime seminar in the Oxford Martin School, University of Oxford, given by Aurora Plomer, professor of law and bioethics at Sheffield University, who described the ruling as having 'serious flaws'.

I was one of a handful of scientists in the audience, which was dominated by lawyers and bioethicists for whom the presentation was more directly aimed. As a result I struggled to appreciate the intricacies of all of Professor Plomer's arguments but she made it immediately clear that this was a landmark case: 'The ruling is extremely important. It is the first time that the Commission's court has inferred legal protection on frozen human embryos, albeit on the back of patent laws'.

With such a contentious subject under scrutiny, I felt compelled to at least try and keep up for the hour-long session.

Professor Plomer began by putting the story into context, starting with the case between Greenpeace and German neuroscientist, Professor Oliver Brüstle. In 1999 Professor Brüstle was granted a patent relating to his work on human ES cells. Greenpeace had challenged the patent in the German courts, which in turn asked the ECJ for its interpretation of 'human embryo' under the 1998 EU Directive on the legal protection of biotechnological inventions (98/44/EC) for it to determine its validity (2). The 1998 Directive states, 'uses of human embryos for industrial or commercial purposes must also be excluded from patentability'.

Professor Plomer admitted that she had been 'looking forward to the ruling', as the 1998 Directive was unclear both in terms of the definition of 'moral' and the scope of the exclusions; did it only apply to embryos or also to cell lines derived from embryos? Greenpeace v Brüstle was to be the case that would answer some of these questions.

She had high hopes that the ruling would be potentially a 'very good intervention'. However, it was not the result Professor Plomer had expected. She was 'dismayed' as the ECJ effectively ruled that the patent ban extended into therapeutic uses of embryos and included any derivative resulting from the destruction of embryos, including ES cells lines.

The ruling surprised Professor Plomer as she believes it achieves the exact opposite of the 1998 Directive on which it is based, which was not supposed to block patents or bring about new laws, but to facilitate competiveness and harmonise existing laws. 'How could the ECJ come to this view? From a legal point it is so problematic', she said.

Interestingly, Professor Plomer points out the contradiction of the ruling, which is 'at odds with the Commission's funding policy on ES cells research'. The EU funds research into ES cells yet bans patent resulting from such work as 'immoral'.

In the many questions following the talk, one attendee asked whether the ruling was a judgment on the morality of the patent system or the morality of the research on human ES cells? Professor Plomer dismissed this distinction, saying that either way it cast a shadow on the morality of the research. She accredited the ECJ with employing religious views, which led it to decide that the patent is immoral because they believe the research is immoral.

A fellow scientist in the audience raised the idea as to whether it was such a bad thing to prevent patents in embryo related work, complaining that patents can lead to stagnation of research. Professor Plomer agreed to some extent, but was worried about the precedent the ECJ had set by going against other directives, and the future implications this could hold.

'It is very important to monitor the developments in the EU now. Clearly the court has plenty of legal material to create further limits', she said. 'We are into uncharted territory, it is bad news really'.

As I left the seminar I was unsure of how the ruling would affect science. In the short term it seems little will change for the lab scientist. The ruling was, after all, about patents not research. It could have a more direct impact for research if funding is cut as a result of the area becoming unprofitable, or if Professor Plomer's fears are recognised and the laws governing scientific research are changed. Scientists will have to watch and wait.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Reviews
15 January 2013 • 5 minutes read

Book Review: Ethical Issues of Human Genetic Databases - A Challenge to Classical Health Research Ethics?

by Dr Gill Haddow

DNA databanks - controversial yet exciting endeavours to collect and store individuals' DNA alongside other information - are the subject of Bernice Elger's latest book, which Gill Haddow describes as fundamental reading...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Reviews
15 January 2013 • 4 minutes read

Book Review: Biotechnological Inventions - Moral Restraints and Patent Law

by Martin Turner and 1 others

By exploring the legislative history and case law of patents both in Europe and the US, Oliver Mills asks why morality has become such a pervasive issue and whether European law in its current state is fit for purpose...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
News
13 December 2012 • 2 minutes read

Ban on embryonic stem cell patents by European Court of Justice

by Dr Antony Starza-Allen

The European Court of Justice (ECJ) has ruled that stem cell processes which require the prior destruction of human embryos or are based upon the use of human embryos are not patentable. The decision may have wide implications for scientists engaged in embryonic stem cell research....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
22 October 2012 • 2 minutes read

European Court of Justice issues opinion on stem cell patenting

by Nishat Hyder

An advisor to the European Court of Justice (ECJ) has issued a preliminary opinion stating that procedures involving human embryonic stem (hES) cell lines are not patentable....

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
8 October 2012 • 2 minutes read

EU research funding programme may not support embryonic stem cell research

by Tom Barrow

The future funding of human embryonic stem cell research under the European Union may be in jeopardy after its inclusion in the next research funding programme is challenged by MEPs....

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
News
8 October 2012 • 3 minutes read

EU urged to continue funding stem cell research

by Dr Antony Starza-Allen

Six major UK research funding bodies have called for the continued funding of human embryonic stem cell (hESC) research in the EU's programme for research and development...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
15 May 2012 • 4 minutes read

'Faithful judgments' in bioethics

by Dr Jackie Scully

We know very little about what 'ordinary' lay members of faith groups - those who are not scientists, philosophers or religious leaders - think about the acceptability of new reproductive and genetic technologies. A team of researchers from Newcastle and Durham Universities is currently carrying out research exploring some of these issues and would like your help...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Book Review: Ethical Issues of Human Genetic Databases - A Challenge to Classical Health Research Ethics?

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
20 June 2022 • 5 minutes read

Documentary Review: Our Father

20 June 2022 • 4 minutes read

Podcast Review: How Far Could Genome Editing Go?

13 June 2022 • 3 minutes read

Podcast Review: Happy Mum Happy Baby – Tom Daley

13 June 2022 • 3 minutes read

Podcast Review: The Outlook – The shocking truth about my three dads

23 May 2022 • 4 minutes read

Documentary Review: Freezing Fertility

1 August 2022 • 3 minutes read

Podcast Review: Stories of Our Times – IVF, fraud and 'unwanted' children

25 July 2022 • 4 minutes read

TV Review: DNA Family Secrets – series two, episode six

18 July 2022 • 4 minutes read

TV Review: Spotlight – The babymaker uncovered

11 July 2022 • 4 minutes read

TV Review: DNA Family Secrets – series two, episode three

4 July 2022 • 3 minutes read

Podcast Review: Biohacked Family Secrets – The birth of the sperm bank

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856